In this compelling episode, we delve into a quiet revolution happening in Lebanon that’s sending ripples across the global oncology community. Dr. Ali Bazarbachi, a physician-scientist at the American University of Beirut (AUB), has dedicated his career to tackling adult T-cell leukemia/lymphoma (ATL)—a rare and deadly blood cancer once deemed incurable.

Through decades of research, Dr. Bazarbachi has upended longstanding beliefs about the disease and pioneered a new treatment strategy targeting the HTLV-1 virus responsible for ATL. His innovative work has quadrupled survival rates and now, with a novel triple therapy, is showing potential for a cure.

Are you a member of the media looking to speak with an AUB expert on this topic or others? Please email [email protected]​​.

Interested in getting stories like this in your inbox? Subscribe to our monthly newsletter! To see more stories like these, click here!​​​​